Market Updates

InterHealth Receives Research Grant

InterHealth Nutraceuticals, Benicia, CA, has received a $100,000 research grant from the National Institutes of Health (NIH) to study the potential benefits of InterHealth’s trans-resveratrol ingredient, Protykin®, as a pharmacological preconditioning agent for use in the treatment and prevention of heart attacks. InterHealth will partner with the University of Connecticut School of Medicine to conduct this research.

Add us as a preferred source on Google

Get the latest Nutraceuticals World news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters